What’s Vulnerable › Vulnerabilities

CVE-2015-3956

• Severity: critical (CVSS 9.8 v3.0)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 1.0% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2019-03-25 · updated 2026-06-17
• Weakness: CWE-345

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Affected products

• Pifzer Plum A+3 Infusion System Firmware: through 13.6
• Pifzer Plum A+ Infusion System Firmware: through 13.4
• Pifzer Symbiq Infusion System Firmware: through 3.13

References

• https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01
• https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01

Get alerted when CVE-2015-3956 or the next vulnerability affects your stack